Showing 961 - 980 results of 101,118 for search '(( 5 fold decrease ) OR ( 5 ((((wt decrease) OR (we decrease))) OR (a decrease)) ))', query time: 2.01s Refine Results
  1. 961
  2. 962
  3. 963
  4. 964
  5. 965
  6. 966
  7. 967
  8. 968
  9. 969
  10. 970

    Selective downregulation of SR Ca<sup>2+</sup> handling proteins and decreased SR Ca<sup>2+</sup> uptake in TG mice hearts. by Mayilvahanan Shanmugam (691549)

    Published 2015
    “…For each atrial Ca<sup>2+</sup> uptake experiment, atria from four mice were pooled. n = 4 for each group. The V<sub>max</sub> of Ca<sup>2+</sup> uptake was obtained at pCa 5.5.…”
  11. 971

    Data_Sheet_5_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…We demonstrated artesunate prevented PINP in a dose-dependent manner, while exerting a clear anti-hyperalgesic effect on already existing PINP. …”
  12. 972
  13. 973

    Participants characteristics. by Sakiko Fukui (387048)

    Published 2025
    “…</p><p>Methods</p><p>Sixty-nine deceased older adults from five special nursing homes were studied over 3.5 years (January 2016 to June 2020). …”
  14. 974
  15. 975
  16. 976

    Pharmacodynamic Profile of CCX168 in Healthy Human Volunteers. by Pirow Bekker (392139)

    Published 2016
    “…CD11b upregulation was diminished in both blood samples from CCX168 subjects with a 10-fold decrease in C5a potency exhibited in the 12-hour samples.…”
  17. 977
  18. 978

    The interaction between E1A and PKA subunits is required for full expression of HAdV-5 E3 and E4 transcripts. by Cason R. King (2633092)

    Published 2016
    “…<p>A549 cells were treated with control siRNA or siRNA specific for PKA subunits (shown in the inset panel) and infected with either WT HAdV-5 or the indicated mutants. …”
  19. 979
  20. 980

    Decreased plaque size in ORP8 KO BM recipients and increased plaque macrophage content after 9 weeks WTD feeding. by Erik van Kampen (649704)

    Published 2014
    “…After 9 weeks of WTD feeding following BMT, a decrease in plaque size could be measured. No difference was observed after 6 weeks of dietary challenge. …”